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Abstract
Many extracellular factors sensitize nociceptors. Often they act
simultaneously and/or sequentially on nociceptive neurons.We
investigated if stimulation of the protein kinaseC epsilon (PKCe)
signaling pathway influences the signaling of a subsequent
sensitizing stimulus. Central in activation of PKCs is their
transient translocation to cellular membranes. We found in
cultured nociceptive neurons that only a first stimulation of the
PKCe signaling pathway resulted in PKCe translocation. We
identified a novel inhibitory cascade to branch off upstream of
PKCe, but downstream of Epac via IP3-induced calcium
release. This signaling branch actively inhibited subsequent
translocation and even attenuated ongoing translocation. A
second ‘sensitizing’ stimulus was rerouted from the sensitizing
to the inhibitory branch of the signaling cascade. Central for the
rerouting was cytoplasmic calcium increase and CaMKII
activation. Accordingly, in behavioral experiments, activation
of calcium stores switched sensitizing substances into desen-
sitizing substances in a CaMKII-dependent manner. This
mechanism was also observed by in vivo C-fiber electrophys-
iology corroborating the peripheral location of the switch. Thus,
we conclude that the net effect of signaling in nociceptors is
defined by the context of the individual cell’s signaling history.
Keywords: CaMKII, hyperalgesia, pain, peripheral nociceptive
neuron, protein kinase C epsilon, sensitization signaling.
J. Neurochem. (2012) 123, 589–601.
Progress in understanding molecular mechanisms of pain
sensitization is enormous. Many extracellular mediators have
been described to act on various classes of receptors
including a-s- and a-q-dependent G-protein coupled recep-
tors (GPCR), ligand-gated ion channels, and hormone
receptors. This activates a variety of intracellular signaling
components, which cause sensitization of peripheral noci-
ceptive neurons (McMahon and Koltzenburg 2005; Hucho
and Levine 2007; Basbaum et al. 2009; Ren and Dubner
2010). Knowledge of intracellular sensitization signaling is
mostly derived from exposure of nociceptive neurons to a
single sensitizing stimulus. But in physiological pain, e.g.,
during inflammation, extracellular mediators are not acting
alone. Instead, nociceptive neurons are exposed simulta-
neously and/or sequentially to a multitude of mediators,
which are present for seconds to days and months (Roos-
terman et al. 2006; Ren and Dubner 2010).
Thus, one has to know if sensitizing agents act cooper-
atively or if they interfere with each other. Besides pain, such
context dependence has been shown among others in a
macrophage cell line. In this cell line, the combination of
two stimuli sometimes is synergistic, but sometimes also
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antagonistic (Natarajan et al. 2006). One cannot simply
predict from a single stimulus the result caused by multiple
stimuli. Whether or not the result of one-stimulus experi-
ments can be extrapolated to multiple-stimuli situations in
peripheral sensory neurons is unknown. Therefore, we set out
to test the context dependence of sensitizing stimuli.
We tested for context dependence on the well-documented
system of protein kinase C epsilon (PKCe)-dependent
sensitization. PKCe is a pivotal intracellular signaling
component in various aspects of pain, including mechani-
cal/thermal sensitization, disease- or drug-induced painful
neuropathy, and the transition from acute to chronic pain
(Khasar et al. 1999a; Aley et al. 2000; Dina et al. 2000;
Joseph and Levine 2003; Parada et al. 2003; Wang et al.
2007, 2011; Eijkelkamp et al. 2010; Bogen et al. 2012). In
nociceptive sensory neurons, PKCe can be activated among
others by epinephrine through the prototypic GPCR,
b2-adrenergic receptor. This leads to cAMP production,
Epac-mediated phospholipase activation, and PKCe activa-
tion (Hucho et al. 2005; Wang et al. 2011). PKCe-mediated
sensitization also can be induced by receptor ligands such as
estrogen and G1, both agonists of the novel estrogen receptor
GPR30 (Hucho et al. 2006; Kuhn et al. 2008). One essential
step in the activation of PKCe is its translocation to a cellular
membrane (Dorn and Mochly-Rosen 2002). In cultures of rat
dorsal root ganglion (DRG) neurons, this translocation is
transient and returns to baseline within 1.5–5 min (Cesare
et al. 1999; Hucho et al. 2005, 2006; Kuhn et al. 2008).
Therefore, in principle, if stimulated for a second time, a
second translocation event could be observable.
Monitoring the percentage of translocating primary sen-
sory neurons, we asked if PKCe translocates repeatedly if
stimulated repeatedly. We identified the molecules regulating
context-dependent signaling in nociceptive neurons. Our
investigation proceeded from molecular to cellular and
living-animal levels. By electrophysiological single-fiber
recordings and behavioral experiments, we confirmed the
context-dependent changes of sensitization signaling, which




Care and use of animals conformed to National Institutes of Health
guidelines and the European Communities Council Directive of
24 November 1986 (86/609/EEC), respectively, and were approved
by the respective boards.
Chemicals and drugs
()-Isoproterenol hydrochloride, Caffeine, dimethylsulfoxide (DMSO),
EGTA, Bovine serum albumin, L-Glutamine, Poly-L-Ornithine
hydrochloride, DMSO, Paraformaldehyde, and TritonX-100
(Sigma, Taufkirchen, Germany), Ryanodine, ESCA (8-CPT-2′-O-
Me-cAMP), IP3 (D-myo-Inositol 1,3,5-Trisphosphate Hexakisacet-
oxymethyl Ester, 2,4,6-Tri-O-butyryl-), Pluronic, Thapsigargin,
UTP, KN-92, KN-93, KN-62, and Autocamtide-2-Related Inhibitory
Peptide (AIP) (Calbiochem, Darmstadt, Germany), Collagenase
P (Roche, Mannheim, Germany), Trypsin (Worthington Biochemical
Corporation, Freehold, NJ, USA), Neurobasal A (without phenol
red), B27 supplement, Laminin, minimal essential medium + Gluta-
max, and Hank’s balanced salt solution (Invitrogen, Germany/UK),
normal goat serum (Dianova, Hamburg, Germany), Fura-2-AM (cell
permeable) (Molecular Probes/Invitrogen), MgSO4 (SERVA, Hei-
delberg, Germany), EDTA (MERCK, Darmstadt, Germany), and
Pen/Strep (Cambrex, East Rutherford, NJ, USA). G1 kindly provided
by Dr. E. Prossnitz.
Antibodies
Anti-PKCe rabbit serum kindly provided by Dr. Robert Messing,
Alexa-488 chicken anti-rabbit IgG obtained from Invitrogen (Kar-
lsruhe, Germany). FITC anti-rabbit IgG obtained from Dianova.
Animals
Behavioral and cell biological experiments were performed with
male Sprague–Dawley rats (200–350 g; Charles River Laboratories,
Hollister, CA, USA, and 200–350 g; Harlan, Borchen, Germany,
respectively).
DRG cultures
Cultures of dissociated DRG were prepared from male Sprague–
Dawley rats as described (Kuhn et al. 2008). Cells were plated
0.5 mL/culture (0.5 DRG equivalents per well) in NeurobasalA/B27
media onto polyornithine/laminin-pre-coated glass coverslips and
incubated overnight at 37°C in 5% CO2.
Cell stimulation and immunocytochemistry
Protocol as published (Kuhn et al. 2008). Stimulants were mixed in
half of the medium of each individual well and added back to the
same culture. Negative controls were mock treated. Hydrophobic
reagents were dissolved in DMSO (final concentration  0.2%).
After stimulation, cells were washed with phosphate-buffered saline
(PBS) and fixed with paraformaldehyde (4%, 10 min, room
temperature). Fixed cells were permeabilized [0.1% Triton X-100
(10 min, room temperature)], washed three times [0.1% bovine
serum albumin (BSA)/PBS, 5 min, room temperature], blocked (5%
BSA/10% normal goat serum in PBS, 1 h, room temperature),
probed with primary antibodies [1% BSA/PBS, overnight (4°C)],
washed (3x 1% BSA/PBS, 5 min, room temperature), and incubated
with secondary FITC-coupled antiserum (final concentration
1 : 500, 1 h, room temperature). After three final washes (PBS,
5 min, room temperature), the cultures were mounted with Fluoro-
mount-G (Southern Biotech/Biozol, Birmingham, AL, USA)
containing DAPI (5 lg/mL).
Evaluation of PKCe translocation
Cells were evaluated using a 63x oil-immersion objective on a Zeiss
Axioplan 2 microscope (Zeiss, Oberkochen, Germany). Per culture,
fifty randomly selected neurons were evaluated for PKCe-translo-
cation, i.e., enrichment of PKCe at the plasma membrane resulting
in a clear rim-like structure. In contrast, cells were considered as
non-translocating if the immunofluorescent signal faded toward the
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plasma membrane. The evaluating scientists were blinded in respect
to the treatment condition of the respective cultures. Data are plotted
as mean percentage of translocating cells. No more than two cultures
treated alike are from the same animal. All experiments have been
repeated on at least two separate days. Images were taken using a
confocal microscope Zeiss LSM 510 [63x oil objective, evaluation
with Image J (NIH, Bethesda, MD, USA)].
Calcium imaging
Overnight cultures of DRG neurons were incubated with Fura-2-
AM (1 lM, 30 min, 37°C, 5% CO2) in Neurobasal A media. After
washing 3x 10 min with Neurobasal A media (37°C, 5% CO2),
responses to isoproterenol (1 lM, 60 s, flow through) were recorded
using a Leica DM IRE2 microscope [(Solms, Germany) imaging
software Simple PCI 6 (Hamamatsu Photonics, Iwata, Japan)].
Paired images of 340/380 nm excitation wavelength were taken
every 2 s. Viability of the cells was assured by final 30 mM KCl
exposure. Only cells with stable baseline and KCl-induced
responses were evaluated.
Combined calcium imaging and PKCe translocation in the same
cell were performed on a BD Pathway 855 High-Content Bioimager.
Overnight cultures of rat DRG neurons in 96-well plates were loaded
with Fura-2-AM as above. Cellular calcium was monitored as above
using a 20x objective in a controlled environment at 37°C, 5%CO2.After
a test pulse of 5 lL Neurobasal A media (1 lL/s), calcium fluxes were
monitored for 30 s. Then, isoproterenol was added (5 lL, f.c. 1 lM,
1 lL/s) and fluxes monitored for 40 s. Cells were fixed [10 min, 8%
PFA added directly to the well (4% final concentration)]. Immunocy-
tochemistry was performed as described above. Cells, which showed
calcium influx, were revisited and evaluated for PKCe translocation
using a 20x objective [(images analyzed with Image J (NIH)].
Single fiber in vivo electrophysiology
Single-fiber recordings were performed as described (Chen and
Levine 1999). Recordings were made from the saphenous nerve of
anesthetized animals (sodium pentobarbital (50 mg/kg intraperito-
neal), additional doses given throughout the experiment to maintain
areflexia). Bipolar stimulating electrodes were placed under the nerve
distal to the recording site. The nerve was cut proximal to the
recording site. Fine fascicles of axons were dissected from the nerve
and placed on a recording electrode. Single units were detected by
electrical stimulation of the nerve. Conduction velocities of fibers
below 2 m/s were classified as C-fibers. Receptive fields of
individual C-fibers were located by mechanical search stimuli (a
blunt probe with smooth tip). The fiber was determined as cutaneous
if lifting and stimulating the skin activated it and/or if the receptive
fields moved when the skin was moved relative to subcutaneous
tissue. These cutaneous C fibers were verified by the latency delay
technique (electrically evoked spikes result in longer latency than if
mechanically stimulated). Mechanical threshold was determined with
calibrated Von-Frey-hairs and defined as the lowest force that elicited
at least two spikes within 1 s, in at least 50% of trials. Neural activity
was recorded using an IBM compatible computer with micro 1401
interface (CED, Cambridge, UK), and further analyzed off-line using
Spike2 software (CED). Isoproterenol and/or Epac were injected in
concentrations and volumes as in the behavioral experiment adjacent
to the receptive field of an identified C fiber. Mechanical threshold
was measured 15 min after the injection.
Testing of mechanical nociceptive threshold in the rat
As published (Dina et al. 2003; Hucho et al. 2006), the nociceptive
flexion reflex was quantified with a Randall–Selitto paw pressure
device (Stoelting, Wood Dale, IL, USA), which applies a linearly
increasing mechanical force to the dorsum of a rat’s hind paw. The
nociceptive mechanical threshold was defined as the force in grams
at which the rat withdrew its paw.
Baseline paw-withdrawal threshold was defined as the mean of six
readings before test-agent injection. Each paw was treated as
independent, and each experiment was performed on a separate
group of rats. Each group of rats was treated with the agonists and/or
inhibitors injected intradermally on the dorsum of the hind paw.
Measurement of nociceptive threshold was taken 30 min after
administration. Inhibitors were injected as described previously
(Khasar et al. 1999a).
Statistical analysis
All statistical comparisons were made with one-way ANOVAs
followed by Dunnett’s test for comparisons with one control, or
Tukey–Kramer post hoc test for multiple comparisons; exception
Fig. 5f–h, where repeated-measure ANOVA was performed. p < 0.05
is considered as statistically significant. Asterisks indicate range of p
values (*p < 0.05, **p < 0.01, ***p < 0.001). Throughout this
manuscript, error bars indicate standard error of the mean, SEM.
Results
First stimulus blocks effect of second stimulus
PKCe-dependent nociceptor sensitization has been described
using b-adrenergic receptor agonists as a model system
(Khasar et al. 1999a, 2008; Hucho et al. 2005; Wang et al.
2011). We stimulated sensory neurons with the b-adrenergic
receptor-specific agonist isoproterenol (for overview of phar-
macological treatments see Fig. 6). As reported previously
(Hucho et al. 2005), stimulation with isoproterenol for 30 s
resulted in translocation of PKCe to the plasma membrane in a
subgroup of about 15–20% of DRG neurons (Fig. 1a and b).
Thus, in isoproterenol-treated cultures, there were non-trans-
locating neurons (Fig. 1a, left) and translocating neurons
(Fig. 1a, middle). The percentage of neurons showing a
translocation is the read out which is monitored in the
following cellular experiments.
We tested if PKCe translocates in nociceptive neurons, a
subgroup of sensory neurons involved in the detection of
painful stimuli. Previously, we described PKCe to be
activated in nociceptive neurons labeled by the isolectin
IB4 (Hucho et al. 2005; Kuhn et al. 2008). Others found
PKCe to regulate the sensitivity of nociceptive neurons
defined by the expression of the transient receptor potential
cation channel, subfamily V, member 1 (TRPV1) (Cesare
et al. 1999; Bhave et al. 2003; Amadesi et al. 2006;
Mandadi et al. 2006). We therefore now tested if isoprote-
renol induces PKCe-translocation in TRPV1-expressing
nociceptive neurons. Double labeling of isoproterenol-stim-
ulated neurons showed TRPV1 to be expressed in
87.5 ± 4.7% of PKC-translocating neurons (Fig. 1c).
© 2012 The Authors
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Fig. 1 Sensitizing signaling initiates long-lasting inhibition of protein
kinase C (PKC)e translocation. (a) The b-AR agonist isoproterenol
(Iso, 1 lM, 30 s) and the Epac-activator ESCA (10 lM, 90 s) trans-
located PKCe in a subgroup of cultured sensory neurons toward the
plasma membrane. Stimulation with Iso (30 s) and then with the
Epac-selective cAMP analogue (ESCA) (90 s) did not result in
observable translocation (scale bar equals 10 lm). (b) Quantification
of PKCe translocation as shown in (a) by dividing the fluorescence
intensity of the plasma–sub plasma membrane region and the center
of the cell as measured along a confocal line scan [Iso (1 lM),
k = 1.83 ± 0.19; Iso + ESCA (10 lM), k = 0.93 ± 0.23, p < 0.001].
(c) Stimulation with Iso (1 lM) showed translocation in TRPV1-
expressing cells. A total of 87.5 ± 4.7% of PKCe-translocating
neurons expressed also TRPV1 (n = 300). (d) Stimulation with Iso
(1 lM) showed translocation at 30 s (the previously reported peak of
translocation) and no translocation at later time points (5.5 min,
30.5 min), independent of whether stimulated once or a second time
cells fixed 30 s after last stimulus application, for positive and
negative controls see white bars, number of evaluated cultures:
n = 6, p < 0.001 (compared to white bar Isocontrol)]. (e) Pretreat-
ment with Iso (1 lM) with intervals ranging from 1 min to 20 h
abolished ESCA (10 $lM)-induced translocation of PKCe [n = 6,
asterisks indicate statistical significance (*p < 0.05, **p < 0.01.
***p < 0.001, comparison to white bar positive controls)]. (f) Also
inverse order of stimulation (first ESCA, then Iso) abolished PKCe
translocation (n = 4, asterisks indicate statistical significance (com-
parison to white bar positive controls), no statistical difference to
untreated controls). Variance in all figures is given as SEM.
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We reported previously that the translocation of PKCe to
the plasma membrane is transient and returns to homogenous
cytoplasmic distribution within 1.5–5 min (Hucho et al.
2005). This fast return to homogenous cytoplasmic distribu-
tion allows, therefore, to test if also a second isoproterenol
stimulus results in a second translocation event.
In accordance with our previous publication (Hucho et al.
2005), we observed translocation of PKCe to the plasma
membrane within seconds after isoproterenol application, but
not at time points beyond 5 min (Fig. 1d).
Finally, to test for the context dependence of PKCe
translocation, we added a first isoproterenol stimulus and
applied isoproterenol for a second time after 5 and 30 min,
respectively. Fixing the cells after additional 30 s (that is
5.5 min and 30.5 min after the application of the first
stimulus, respectively), the second stimulus did not induce a
second translocation (Fig. 1a, b and d).
Inhibition of translocation is not caused by
receptor desensitization
Several receptor-desensitization mechanisms are known.
They occur usually within a few seconds, last for minutes,
and result in attenuation of ligand-induced intracellular
signaling. Such a mechanism might underlie the lack of
effect of a second isoproterenol application (Lohse et al.
1990; Daaka et al. 1997). To exclude receptor desensitiza-
tion, we therefore next attempted to induce translocation first
by activating the receptor with isoproterenol and then to
activate the downstream signaling component, Epac, with
the membrane-permeable ‘Epac-selective cAMP analogue’
[ESCA (also referred to as ‘CPTOMe’ or ‘007′)] (Rehmann
et al. 2003; Hucho et al. 2005).
As described earlier, treatment with ESCA alone resulted
in PKCe translocation similar to isoproterenol stimulation
(peak of translocation was reported to be at 90 s, (Hucho
et al. 2005), Fig. 1e). Adding ESCA for additional 90 s after
an initial isoproterenol treatment, we could not observe a
second PKCe-translocation event (Fig. 1a, b and e). This was
true for interstimulus intervals of 1 min to 20 h. We could
never detect a second translocation. Thus, our results showed
that the block of a second PKCe translocation is located
downstream of the receptor. It also showed that the block of a
second PKCe translocation is fast (within 1 min) and, in
contrast to common receptor-desensitization processes, rather
long lived [over 20 h, Fig. 1e (longest observable time point
with this model system)].
The inhibition of a second translocation is initiated
at Epac or downstream of it
Next, we attempted to narrow down where the blocking
signaling is initiated. We tested if it is initiated upstream or
downstream of ESCA-activated Epac. Therefore, we changed
the order of stimulation. We first stimulated Epac with ESCA
and then the receptor with isoproterenol. If the block of a
PKCe translocation is initiated upstream of Epac, then a
second induction of translocation should now be possible.
This order of stimulation, too, resulted in blocking of a
second PKCe translocation (Fig. 1f). Thus, the long-term
inhibitory signaling cascade counteracting PKCe transloca-
tion is activated at or downstream of Epac.
A second stimulation abolished an ongoing
sensitization signaling
When switching the order of stimulation from Isoproterenol/
ESCA to ESCA/Isoproterenol, the shortest time interval
revealed an additional aspect. There, Isoproterenol was added
60 s after the addition of ESCA and stimulation continued in
the presence of both substances for further 30 s. Thus, the
cultures were fixed after a total of 90 s of ESCA stimulation,
including a total of 30 s of isoproterenol stimulation. At this
time point, both ESCA and isoproterenol should have
induced maximal translocation. But, we could not detect
any significant PKCe translocation (Fig. 1f).
This suggests that the ESCA-initiated PKCe translocation
is abrogated by the application of the second stimulus,
isoproterenol. Thus, potentially a second stimulus is not
simply blocked. Instead, the second stimulus resulted in
active signaling. This signaling was potentially then rerouted
from a translocation-initiating to a translocation-abrogating
signaling. In the following experiments, we investigated this
hypothesis further in detail.
Inhibitory signaling is separable from sensitizing signaling
To further characterize this inhibitory signaling, we mapped
the point in the cascade where the inhibitory signaling is
initiated.We had found the inhibitory signal to be derived from
signaling at or downstream of Epac (see above). Branching
might occur at the level of phospholipase C, which produces
diacylglycerol and IP3, the former activating PKCwhereas the
latter induces calcium release from internal calcium stores
(Hucho et al. 2005). PKCe is a ‘novel PKC’ lacking a calcium-
binding domain. Thus, we considered an IP3-induced calcium
release unlikely to modulate PKCe activation (Parekh et al.
2000). Nevertheless, to exclude this signaling branch, we
inhibited the IP3 receptor with 2-Aminoethoxydiphenyl borate
(2APB). Surprisingly, we observed a reversal of the PKCe-
translocation block. Thus, in presence of 2APB, PKCe translo-
cation was observed also after a second stimulation (Fig. 2a).
2APB has been reported to have various effects in addition
to blocking IP3 receptors (Parekh and Putney 2005). Thus, the
mechanism underlying the effect of 2APB had to be clarified.
If indeed the block of the IP3 receptor enabled a second PKCe
translocation, then in turn the activation of the IP3 receptor
should block PKCe translocation. We used a membrane-
permeable IP3 analogue to activate the IP3 receptor. Indeed,
pre-treatment with IP3 led to blockade of PKCe translocation
in response to ESCA and ESCA/Iso stimulation (Fig. 2b).
This corroborates the result of the 2APB-pre-treatment
© 2012 The Authors
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experiment and suggests IP3 and the IP3 receptor to be
involved in the rerouting of sensitizing signaling.
Activation of P2Y receptors block subsequent
PKCe translocation
To further confirm that the IP3/calcium signaling branch
induces the block of subsequent PKCe translocation, we tested
if also IP3 produced endogenously after receptor activation
would lead to abolishment of Epac-initiated PKCe transloca-
tion. Metabotropic a-q-coupled P2Y receptors are activated
by UTP and result in IP3 production in primary nociceptive
neurons (Ralevic and Burnstock 1998; Sanada et al. 2002;
Gerevich and Illes 2004). And indeed, as predicted by our
previous results, 30-min pre-treatment with UTP abolished the
induction of PKCe translocation completely (Fig. 2c).
IP3 and ryanodine receptor mediate the inhibition of
PKCe-translocation
IP3 receptors regulate calcium influx from intracellular stores
and from extracellular space, and are involved in calcium-
independent signaling (Bolotina 2004; Dellis et al. 2006).
Not only IP3 receptors, but also ryanodine receptors mediate
rise of cytoplasmic calcium. If our reasoning is correct and a
rise of intracellular calcium is essential for the inhibition of
PKCe translocation, then also raising intracellular calcium
via the ryanodine receptor should abolish PKCe transloca-
tion. To test this, we pre-treated primary DRG cultures for
30 min with ryanodine, a ryanodine-receptor activator, or
with caffeine, a ryanodine-receptor activator, and concom-
itant IP3-receptor inhibitor. Both treatments blocked ESCA-
induced PKCe translocation (Fig. 2d). Thus, indeed, the
PKCe block appears to depend not exclusively on IP3
receptor-mediated calcium rise, but can also be mediated by
other calcium channels such as the ryanodine receptor.
Rise of intracellular calcium causes inhibition of
PKCe translocation
IP3-mediated activation of the IP3 receptor results in a rapid
increase of intracellular calcium. Therefore, to further
corroborate our pharmacological results, we next tested
whether isoproterenol treatment leads to a rise in intracellular
calcium. Furthermore, we tested if this calcium change
occurs in cells translocating PKCe, and if this calcium
change is essential for the inhibition of translocation.
Using Fura-2-based calcium imaging, we found that
neurons react to isoproterenol with a pronounced change in
the concentration of cytoplasmic calcium (Fig. 3a and c).
PKCe translocation by sensitizing stimuli such as epineph-
rine, isoproterenol, estrogen, and GPR30-specific derivatives
of estrogen occur only in about 15% of all sensory neurons in
culture (difference between unstimulated and stimulated
cultures) (Hucho et al. 2005; Kuhn et al. 2008). Corre-
spondingly, stimulation with isoproterenol resulted in cal-
cium influx in 16.7% of the cultured neurons.
We next tested if the change of intracellular calcium can be
observed not only in a similar percentage of neurons but in
the very same cells as the PKCe translocation. We performed
(a) (b)
(c) (d)
Fig. 2 Protein kinase C (PKC)e-translocation-inhibiting pathway
branches off via IP3 and can be activated pharmacologically as well
as through endogenous receptor-mediated processes. (a) Dimethyl-
sulfoxide (DMSO) in the concentration used (f.c. in culture 0.2%) did
not affect PKCe translocation after Epac-selective cAMP analogue
(ESCA) (10 lM) and Iso (1 lM) stimulation. Also pre-treatment with
the DMSO-solved IP3R blocker, 2-Aminoethoxydiphenyl borate
(2APB) (178 lM), alone did not interfere with Iso and ESCA single-
stimulus induction of PKCe translocation. But, PKCe translocation was
observable in cultures stimulated with both stimuli (ESCA and Iso) if
pre-treated with 2APB (number of evaluated cultures: n = 6, asterisks
indicate statistical significance [comparison to white bar 30’ DMSO
control)]. (b) Activation of the IP3 receptor with IP3 (100 lM) in its
solvent DMSO + Pluronic (D+P) (f.c. in culture 0.02%) abolished
translocation in response to a first (ESCA, 10 lM) as well as
subsequent second stimulus [Iso, 1 lM, number of evaluated
cultures: n = 6, asterisks indicate statistical significance (comparison
to white bar positive controls)]. (c) UTP (100 lM)-mediated activation
of the P2Y receptor, which produces endogenously IP3, resulted in
block of translocation [number of evaluated cultures: n = 6, asterisks
indicate statistical significance (comparison to white bar positive
controls)]. (d) Translocation was abolished by pre-treatment with the
ryanodine receptor agonists, Ryanodine (10 lM) or caffeine (10 mM),
the latter being also an IP3R inhibitor [number of evaluated cultures:
n = 8, asterisks indicate statistical significance (comparison to white
bar positive controls)].
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live-cell calcium imaging followed by fixation 30 s after
isoproterenol application and evaluated the very same cells
for PKCe translocation. Indeed, in DRG neurons with
isoproterenol-induced calcium rise, we also observed PKCe
translocation (Fig. 3a and b).
To test directly if calcium underlies the inhibition of PKCe
translocation, we depleted calcium from both internal as well
as external sources by thapsigargin and EGTA exposure.
Indeed, in the absence of a calcium rise, ryanodine no longer
induced a block of PKCe translocation (Fig. 3d). Neither
EGTA nor thapsigargin alone abolished the ryanodine effect,
indicating that calcium from either intracellular or extracel-
lular sources is sufficient for the block of PKCe signaling
(Fig. 3e).
Finally, we investigated if an increase of intracellular
calcium not only abolishes future but also ongoing translo-
cation. We added the inducers of calcium release from
intracellular calcium stores, ryanodine, IP3, as well as UTP,
overlapping for 60 s with ESCA. Indeed, as with the
overlapping isoproterenol signaling presented above
(Fig. 1f), the already started ESCA-induced translocation
was completely abolished (Fig. 4a).
CaMKII inhibitors abolish the switch to
translocation-inhibiting signaling
We showed that the rise of intracellular calcium is a
prerequisite for the change from PKCe translocation to
PKCe-translocation-inhibitory signaling. Now, we attempted
to characterize an effector of calcium, which initiates the
block. One calcium-dependent component central to long-
lasting changes in neurons is CaMKII (Silva et al. 1992).
If CaMKII indeed is activated by the rise in calcium, and if
this change indeed is central for the long-lasting inhibition of
a second translocation, then blockers of CaMKII should
attenuate this effect. Consequently, in the presence of
blockers of CaMKII, translocation of PKCe should be
observable also after application of the second stimulus.
We tested the CaMKII inhibitors, KN93, KN62, and the
CaMKII-inhibitory peptide, AIP. Indeed, the percentage of




Fig. 3 Rerouting switch is calcium dependent. (a) Isoproterenol
stimulation resulted in an increase of intracellular calcium in 16.7%
of the neurons corresponding well with the detected 15% of protein
kinase C (PKC)e-translocating neurons. Shown are representative
images of Fura-2 loaded Iso-responding ‘positive’ and Iso-non-
responding ‘negative’ cells. The 340/380 nm ratio has been converted
into false colors. Images were taken approximately every 2 s
(numbers underneath indicate image number). (b) Calcium rise was
found to occur in PKCe-translocating neurons (epifluorescent images
of PKCe immunfluorescence of the same two cells as in (a), above.
Intensity histograms along the indicated red lines are presented. The
red star indicates the nuclei of the cells). (c) Exemplary traces of
responsive (red symbols) and non-responsive (blue symbols) rat
dorsal root ganglion (DRG) neurons shown in (a) and (b). Arrows
indicate the test pulse and the addition of Iso as well as of PFA.
(d) Pre-treatment with Thapsigargin plus EGTA (T + E, 1 lM and
2.5 mM, respectively) to deplete intracellular calcium stores as well as
extracellular calcium abolishes ryanodine-induced block of PKCe
translocation [number of evaluated cultures: n = 6, asterisks indicate
statistical significance (comparison to white bar untreated controls)].
(e) Neither treatment with Thapsigargin nor with EGTA alone
abolished Ryanodine-induced block of PKCe translocation [number
of evaluated cultures: n  4, asterisks indicate statistical significance
(comparison to white bar positive controls)].
© 2012 The Authors
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of these three inhibitors was as high as in the single-stimulus
controls (Fig. 4b). For the inhibitor KN93, an inactive
control compound, KN92, is available. As expected, the
control compound KN92 did not affect the inhibition of the
second translocation. In conclusion, CaMKII mediates the
rerouting of sensitizing signaling to translocation inhibition.
Switch to inhibitory signaling erases mechanical
hyperalgesia in animals
Next, we verified that the inhibitory signaling of a second
stimulus is also present in the living animal, thereby reversing
an already established hyperalgesia.We injected isoproterenol
intradermally into the hind paw of adult male rats at a
concentration known to induce PKCe-dependent mechanical
hyperalgesia [measured by the Randall–Selitto paw pressure
test (Khasar et al. 1999a, b)]. After 30 min, when robust
hyperalgesia was detectable, the second stimulant (ESCA)was
injected. As in the cellular experiments, this second stimulus
completely reversed the sensitization (Fig. 5a).
We confirmed this effect with another sensitizing stimulus,
with the estrogen derivative specific for GPR30, G1 (Hucho
et al. 2006; Kuhn et al. 2008). G1-induced mechanical
hyperalgesia was completely reversed by a subsequent ESCA
injection (Fig. 5b). Thus, also in the animal, the switch
to sensitization-inhibiting signaling was not restricted to the
b2-adrenergic receptor.
If the reversal of hyperalgesia is based on the same
mechanism as shown in the cellular experiments, one would
predict the results of the following three experiments:
Ryanodine should (i) block the development of hyperalgesia,
and (ii) reverse already established hyperalgesia; and iii)
CaMKII inhibitors should abolish the inhibitory effect of
isoproterenol given as second stimulus.
Ad (i) Ryanodine injected alone had no effect on the
mechanical nociceptive threshold in the rat. But, when
injected 30 min before ESCA, ryanodine completely atten-
uated ESCA-induced mechanical hyperalgesia (Fig. 5).
Ad (ii) If injected after ESCA, ryanodine completely
reversed mechanical hyperalgesia (Fig. 5d).
Finally, ad (iii): We pre-treated the rat paw by intrader-
mally injecting the CaMKII inhibitor KN93 at concentrations
as low as 10 ng/2.5 lL. This pre-treatment completely
blocked the isoproterenol-induced reversal from ESCA-
induced hyperalgesia to baseline sensitivity (Fig. 5e).
To go beyond the hyperalgesic model used in this investi-
gation, we tested if the switch to inhibitory signaling abolishes
hyperalgesia also in a more complex model of mechanical
hyperalgesia. Indeed, activation of the rerouting switch by
ryanodine completely attenuated the mechanical hyperalgesia
induced by Carrageenan-evoked inflammation (Fig. 5f).
In conclusion, antihyperalgesia in the living animal
appears to rely on the switch/rerouting of intracellular
signaling, which we described on a cellular level. Thus,
prevention of sensitization can be accomplished through
activation of an endogenous signaling cascade distinct from
the sensitizing PKCe pathway.
Prevention of sensitization in single-fiber
recordings – a peripheral mechanism
Our results indicate that sensitivity can be steered by
stimulation of a rerouting switch in sensory neurons. To
confirm that this is a peripheral mechanism, we recorded
the reversal of sensitization electrophysiologically directly
from single afferent nerve fibers in living animals. The
nerves are cut between the site of recording and the spinal
cord. Thus, any change of action-potential response arriving
from the periphery can only be modulated by peripheral
tissue, not by the spinal cord. Injected into the receptive
field on the hind paw of the respective nerve fiber,
isoproterenol as well as ESCA, each resulted in increased
sensitivity to mechanical stimuli as tested with Von-Frey-
hairs (Fig. 5g and h). However, apparently a first sensiti-
zation switched the signaling so that a subsequent second
stimulus was rerouted and reversed the already established
sensitization (Fig. 5h).
Discussion
Here, we describe a novel endogenous intracellular inhibitory
mechanism regulating hyperalgesia. We show that the
signaling pathway toward PKCe and thus toward PKCe-
dependent hyperalgesia branches and activates a so far not
described inhibitory pathway. This inhibitory pathway is
located downstream of known negative feedback loops of
(a) (b)
Fig. 4 The rerouting reverses ongoing sensitizing signaling. (a) Stim-
ulation of calcium release by ryanodine (10 lM), IP3 (100 lM), or UTP
(100 lM) reversed ongoing sensitization signaling leading to protein
kinaseC (PKC)e translocation even if applied after Epac-selective cAMP
analogue (ESCA) treatment [number of evaluated cultures: n > 4,
asterisks indicate statistical significance (comparison to white bar
positive controls)]. (b) The CaMKII inhibitors KN-93 (10 lM), KN-62
(5 lM), AIP (1 lM), but not the control compound KN-92 (10 lM)
abolished the inhibitory effect of ryanodine on PKCe translocation
[number of evaluated cultures: n > 6, asterisk indicates statistical
significance (comparison to white bar untreated, ESCA, Iso controls)].
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Fig. 5 Reversal of hyperalgesia through second sensitiziation stimu-
lus in rat behavior - a peripheral mechanism. (a) Injection of
isoproterenol (1 lg/2.5 lL) or Epac-selective cAMP analogue (ESCA)
(6.3 lg/2.5 lL) intradermally into hind paws of male rats resulted in
robust mechanical hyperalgesia after 30 min. The hyperalgesia fully
established 30 min after the initial isoproterenol injection was reversed
back to baseline if followed by ESCA injection [measurement taken
30 min after the ESCA injection, n > 8, asterisks indicate statistical
significance (comparison with white positive controls)]. (b) Successive
stimulation reversed mechanical hyperalgesia also if induced through
the estrogen derivative G1 acting on a different G-protein coupled
receptor (GPCR), GPR30 than isoproterenol [n = 6, asterisks indicate
statistical significance (comparison with white positive control)]. (c)
Pre-treatment with ryanodine (2.5 lg/2.5 lL) attenuated ESCA-
induced hyperalgesia [asterisks indicate statistical significance (com-
parison with white bar positive controls)]. (d) Activation of the inhibitory
module with ryanodine reversed ESCA-induced hyperalgesia [n > 8,
asterisks indicate statistical significance (comparison with white bar
positive controls, p > 0.05 comparison ryanodine vs. ESCA/ryanodine
treatment)]. (e) Injection of the CaMKII inhibitor, KN-93 (10 ng/2.5 lL)
blocked completely the switch of the second stimulus (Iso) into an
antinociceptive reagent. Thus, the hyperalgesia induced by ESCA
injection was maintained even after the injection of isoproterenol
(n > 4). (f) Injection of ryanodine (2.5 lg/2.5 lL) blocked inflammatory
mechanical hyperalgesia induced by injection of carrageenan (1%,
2.5 lL, 15 min after ryanodine, ryanodine + carrageenan n = 6,
saline + carrageenan n = 4, asterisks indicate statistical significance).
(g) Intradermal injection of ESCA resulted in mechanical hyperalgesia
as measured by single-fiber recordings in the living animal in
response to Von-Frey-hair mechanical stimulation (7 of 12 fibers
reduced their threshold, mean of all 12 are shown, p = 0.014). (h)
Injection of ESCA into isoproterenol-sensitized skin reversed the
hyperalgesia [12 of 23 fibers sensitized by isoproterenol (52%), 7 of
12 sensitized fibers returned to baseline (58%), mean of all 23 fibers
shown for all three conditions, asterisks indicate statistical significance
(comparison with white bar positive control)].
© 2012 The Authors
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GPCRs, such as the G-protein switch, b arrestin coupling/
signaling, or internalization (Lohse et al. 1990; Daaka et al.
1997). In contrast to known GPCR regulation mechanisms,
which over a few minutes result in fading of newly initiated
signaling such as cAMP production, the signaling character-
ized here seems not to be a simple negative feedback loop.
Instead, prior stimulation determines not only the outcome of
future sensitizing stimuli quickly (1 min), but also long-term
(investigated up to 20 h) outcomes.
We found the same mechanism not only to inhibit future
stimulation of sensitizing PKCe signaling but to reverse
also ongoing as well as past sensitization. Interestingly, this
antihyperalgesic action can be separated from the sensitiz-
ing signaling cascade. Thus, pharmacologically sensitization
signaling could be reverted in cell culture and hyperalgesia
inverted in the living animal. Interestingly, desensitization
was accomplished not by the blocking of signaling, but by
the initiation of endogenous signaling cascades. Our data
suggest that, thereby, the signaling was switched from a
sensitization to a desensitization pathway. For the switch to
desensitization signaling, an increase of intracellular
calcium and the activation of CaMKII is essential. As an
endogenous mechanism in the periphery is targeted, and as
the observed inhibition of PKCe translocation lasts for at
least 20 h, the sensitization-rerouting switch could be a
powerful and conceptually novel way for therapeutic
intervention.
Several aspects of calcium and CaMKII in hyperalgesia
have been described already. For example, increased intra-
cellular calcium results in desensitization of TRPV1 (Caterina
et al. 1997; Numazaki et al. 2003). Also, desensitization is
the result of direct phosphorylation of TRPV1 by CaMKII, a
kinase activated by elevated calcium levels (Price et al.
2005). Accordingly, lowering of intracellular calcium con-
centrations has been correlated with increased spontaneous
activity of nociceptive neurons (Fuchs et al. 2005; Hogan
et al. 2008). Surprisingly, not only the increase but also the
block of CaMKII activity has been reported to ablate
hyperalgesia (Fang et al. 2002; Chen et al. 2010; Liang
et al. 2011; Matsumura et al. 2011). Some of these seemingly
contradictory results might be attributed to differential effects
of CaMKII if activated in the peripheral versus central
nervous system. On the basis of our results, we suggest an
alternative explanation. CaMKII appears to be not only
involved in the direct action on effector ion channels, such as
TRPV1. Instead, it also regulates the sensitization signaling
network, which is involved in the computation of sensitizing
inputs and which is initiated mainly by GPCRs.
Extracellular mediator-dependent nociceptor sensitization
has been widely reported. The response of the nociceptive
neuron to a physical stimulus like pressure or temperature is
altered if the environmental context is altered by e.g., an
ongoing inflammation. We now tested for an additional aspect
of context dependence. We investigated if not only the
environmental context but also the intracellular signaling
context itself results in modulation of sensitization. Informa-
tion concerning this is important, as in physiological condi-
tions like inflammation, more than one GPCR is activated. It is
also important, as one is tempted to assume that one can simply
combine results of the common one-stimulus approaches to
explain the outcome of multiple-stimuli experiments.
One central conclusion of our study is that the result of the
combination of sensitizing stimuli cannot be deduced simply
from responses of sensitizing agents, which were applied
individually. We show that known sensitizing stimuli such
as isoproterenol, ESCA, and estrogen receptor GPR30-
specific G1 can be converted to antinociceptive signaling
depending on the signaling context (see Fig. 6 for over-
view). Apparently, the information, if a stimulus is sensi-
tizing or desensitizing, is not encoded in the extracellular
mediator itself. Instead, the cell has far-reaching abilities to
‘interpret’ the incoming information. In our experiments, the
Fig. 6 Calcium and CaMKII rule over the switch from pro- to
antialgetic signaling. Activation of a-s-coupled GPCRs initiates pro-
algetic signalling (red arrow) via adenylyl cyclase (AC), cAMP, Epac,
phospholipase C (PLC) and protein kinase C (PKCe), resulting in
hyperalgesia. We now found in addition PLC to activate via IP3 a
switch (black bold lines underlined by white sphere). Thereby, the
signaling initiated by subsequent stimulation of the Epac pathway is
rerouted to the antialgetic signaling (green arrow) reversing already
established hyperalgesia. The rerouting switch can be also activated
through pharmacological stimulation of the IP3 receptor (IP3R) or the
ryanodine receptor (RyR) as well as through a-q-coupled GPCRs
such as the P2Y ATP/UTP receptor. Substances blocking calcium
release or calcium calmodulin-dependent kinase CaMKII also block
the switch to the antialgetic signaling (see substances in light grey).
The positioning of the switch represents two complementary compu-
tation states of one and the same cell: either ‘sensitizing’ stimuli
induce sensitization of nociceptive neurons or they are ‘interpreted’ by
the neuron as antialgetic thereby erasing already established hyper-
algesia. Thus, the result of stimulation is not only dependent on the
proteins expressed but also on the signaling context of each single
cell.
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outcome of such ‘interpretation’ goes even to the extreme
that a ‘sensitizing’ stimulus results in desensitization. This is
very much in agreement with results obtained with a
macrophage cell line, where the combination of two stimuli
resulted in synergistic but also antagonistic effects in an
often unexpected, but defined and context-dependent manner
(Natarajan et al. 2006). Thus, the current differentiation of
extracellular mediators into sensitizing and non-sensitizing
has to be taken with caution. The stimulus context is
apparently of considerable significance for the cellular
nociceptive response.
The dependence of sensitizing mediators on the stimulus
context is a great challenge. The outcome of various
combinations of well-known “sensitizing” stimuli such as
PGE2, 5HT, growth factors, Bradykinin, and others has to be
established in experiments with two and more stimuli. But
with any additional stimulus, the degree of freedom and thus
the number of control experiments to be performed increases
considerably. Not only the stimuli, but also the order of all
stimuli, including the variation of time intervals between
them have to be tested. Nevertheless, the possibility of non-
additivity and even inversion of sensitizing stimuli illustrates
the need to better understand pain sensitization in more
complex, i.e., more physiological context.
We found sensitization signaling to be blocked quickly
and long lastingly. One important aspect, which requires
further investigation, is to analyze, which mechanism
maintains this long-term inhibition. Bistable positive forward
loops of kinases were shown to accomplish such stable
context memory e.g., in Xenopus eggs (Xiong and Ferrell
2003). One kinase activated by increases in calcium is
CaMKII. This kinase was found to be essential for the
establishment of long-term changes in the CNS, such as
long-term potentiation. A recent report indicates that the
pharmacogenetic over-activation of CaMKII results in
memory extinction in the CNS (Cao et al. 2008). In
accordance with a positive forward loop underlying cellu-
lar-context memory proposed by Ferrel et al., CaMKII can
long lastingly increase the intracellular calcium concentration
(Curran et al. 2007). Indeed, one might take calcium traces
such as shown in Fig. 3a as a first indication for such an
increased homeostatic level of cytoplasmic calcium, although
this has to be investigated in detail in future works.
Calcium homeostasis is central to nociception. Calcium
concentration in peripheral sensory neurons in models of
experimental neuropathic pain has been shown to be lowered
(Fuchs et al. 2005). Hogan et al. found that an increase of
the constitutively lowered calcium concentration in DRG
neurons reverses hyperexcitability (Hogan et al. 2008).
Interestingly, they also found hyperexcitability to correlate
with reduced CaMKII responsiveness (Kawano et al. 2009).
Our findings are complementary to theirs, showing that an
increase of cytoplasmic calcium results in a block of future
sensitizing pathways as well as reversal of established
hyperalgesia. Thus, Hogan and our results suggest that some
mechanisms central to neuropathic and inflammatory pain
might be shared and are potentially sites for intervention.
CaMKII and Epac play an important role in long-term
potentiation (Lisman et al. 2002; Gekel and Neher 2008).
Thus, it will be interesting to investigate, if similar signal
inversions exist in the CNS mediated by a similar context
dependence as shown for the peripheral nociceptive neuron.
This is of special interest as we have shown desensitization
through activation of endogenous signaling pathways.
Thereby, we extend mechanisms for loss of memory which
have been described in the CNS to occur following lack of
reconsolidation (Debiec et al. 2006), pharmacological inhi-
bition of maintenance mechanisms (Ling et al. 2002; Shema
et al. 2007), or after pharmacogenetic change of CaMKII
activity (Cao et al. 2008).
In conclusion, we have characterized a counterintuitive
aspect of cellular signal integration. We have shown that
sensitizing signaling can have a desensitization signaling
branch. This branch not only blocks but inverts a sensitiza-
tion signaling pathway resulting in desensitization. This
inversion was not dependent on protein expression as in
other examples of context dependence, but on the signaling
activity in nociceptive neurons (Hucho et al. 2005; Rush
et al. 2006). Our results thereby indicate that peripheral pain
can be attenuated by the activation (sic) and rerouting (sic) of
endogenous signaling cascades, which could decouple e.g.,
inflammatory processes important for tissue regeneration
from pain sensitization. This could be of therapeutic impor-
tance for the therapy of ongoing pain as well as preemptive
treatment.
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